21. November 2009 00:40
Dr. Jeremy Schmahmann, Professor of Neurology at Harvard Medical School and neurologist at the Massachusetts General Hospital in Boston, on Thursday, November 19, presented his laboratory's research on the new field of study called "Connectivity" at the launch of the MINDlink Foundation.
[More]
20. November 2009 23:40
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
[More]
eb34af81-8141-4574-b270-52cb5d01cd03|0|.0
Posted in: Child Health News | Pharmaceutical News
Tags: Abilify, Antidepressant, Antipsychotic, Autism, Bipolar Disorder, Blood Pressure, Cardiovascular Disease, Cell, Cerebrovascular Disease, Constipation, Creatinine, Dehydration, Dementia, Depression, Diabetes, Diabetes Mellitus, Dystonia, Exercise, Heart Failure, Hyperglycemia, Hypersensitivity, Insomnia, Leukopenia, Lipids, Nausea, Neutropenia, New Drug Application, Obesity, Pediatrics, Pneumonia, Psychosis, Schizophrenia, Speech, Stroke, Tardive Dyskinesia, Urticaria, Vomiting
20. November 2009 00:00
Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at three additional clinical trial sites.
[More]
19. November 2009 07:38
Pennsylvania is expected to see a continued rise in the number of children and adults living with autism, according to the Pennsylvania Autism Census Project Final Report released today by Governor Edward G. Rendell.
[More]
19. November 2009 06:55
Research and Markets (http://www.researchandmarkets.com/research/d3e55b/pediatric_board_re) has announced the addition of the "Pediatric Board Review" report to their offering.
[More]
d4ec9abc-91de-438c-89da-9ba0d7241de0|0|.0
Posted in: Child Health News
Tags: Allergy, Autism, Biochemistry, Cardiology, Dermatology, Education, Endocrinology, Gastroenterology, Genetics, Hematology, Hospital, Immunology, Learning Disability, Metabolism, Nephrology, Neurology, Nutrition, Obstetrics, Oncology, Ophthalmology, Orthopedic, Pediatrics, Psychiatry, Radiology, Rheumatology, Sports Medicine
18. November 2009 07:12
Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Although this belief has been refuted, a University of Missouri occupational therapy professor believes that the current health system is still not giving patients enough time to recover and underestimating what the human brain can do given the right conditions.
[More]
18. November 2009 06:15
During its research into the application of neuroscience in business, a New Jersey based think tank, The Center for Modeling Optimal Outcomes®, LLC (The Center) made an inadvertent and amazing discovery.
[More]
17. November 2009 00:17
Adults who use pet therapy while recovering from total joint-replacement surgery require 50 percent less pain medication than those who do not. These findings were presented at the 18th Annual Conference of the International Society of Anthrozoology and the First Human Animal Interaction Conference (HAI) in Kansas City, Mo.
[More]
13. November 2009 00:08
UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.
[More]
5d809b02-81fc-45a8-b606-54c347a5fe67|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Autism, Biochemistry, Brain, Brain Tumor, Cancer, Cardiology, Cardiovascular Disease, Diabetes, Genomics, Glioblastoma, Hepatitis C, Kidney Disease, Liver Cancer, Lung Cancer, Metabolism, Neurology, Oncology, Psychiatry, Radiology, Vaccine, Virus
12. November 2009 06:07
A new study carried out at the University of Haifa has found that oxytocin, also known as the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.
[More]
12. November 2009 04:29
Autism Speaks is encouraged by yesterday's decision of the Interagency Autism Coordinating Committee (IACC) to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research. The new language, approved unanimously, calls for studies to determine if there are sub-populations that are more susceptible to environmental exposures such as immune challenges related to naturally occurring infections, vaccines or underlying immune problems.
[More]
11. November 2009 00:15
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
[More]
10. November 2009 06:43
Research conducted by the Center for Autism and Related Disorders, Inc. (CARD), shines new light on the effects of a popular form of hyperbaric oxygen therapy (HBOT) treatment for children with autism and related disorders. The "Randomized Trial of Hyperbaric Oxygen Therapy for Children with Autism" study reveals that HBOT, consisting of 24% oxygen delivered at 1.3 atmospheres of pressure, does not have a significant effect on symptoms of autism.
[More]
10. November 2009 04:29
Autism Spectrum Therapies, an agency providing behavior therapy and other autism services in Southern California, has been approved to provide behavioral services for TRICARE military insurance beneficiaries. This designation makes AST eligible to deliver Applied Behavior Analysis (ABA) services to individuals with autism in military families in the San Diego area.
[More]
10. November 2009 01:41
Handwriting skills are crucial for success in school, communication, and building children's self-esteem. The first study to examine handwriting quality in children with autism spectrum disorders (ASD) has uncovered a relationship between fine motor control and poor quality of handwriting in children with ASD, according to research published in the November 10, 2009, issue of Neurology-, the medical journal of the American Academy of Neurology.
[More]